"

 

From 2009.igem.org

Chapitre	Ref.	Auteurs	Titre	Lien
Current Therapies	[1]	Lechat P.	Pharmacology	2006
Current Therapies	[2]	Bruguerolle B.	Biological rhythms and medications: a source of variability often neglected in pharmacology	2008
Current Therapies	[1]	Kevin J. Scanlon and al.	Cancer Gene Therapy: Challenges and Opportunities	2004
Gene Therapies	[2]	Gouze JN and al.	A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer	2003
Gene Therapies	[3]	Centre for Genetics Education	http://www.genetics.com.au/index.asp	XXXX
Vectorization	[1]	Couvreur P.	L'encapsulation de médicament	2003
Vectorization	[2]	Andrieux K. and al.	Nanotechnology and new drug	2003
Vectorization	[3]	Torchilin V.P.	Recent Approaches to Intracellular Delivery of Drugs and DNA and Organelle Targeting	2006
Vectorization	[4]	Davis M.E. and al.	Nanoparticle therapeutics: an emerging treatment modality for cancer	2008
Vectorization	[5]	Seow Y. and al.	Biological Gene Delivery Vehicles: Beyond Viral Vectors	2009
Vectorization	[6]	Decroly E.	Vectorology	2005
Vectorization	[7]	Robbins P.D. and al.	Viral Vectors for Gene Therapy	1998
Vectorization	[8]	Wei M.Q. and al.	Bacterial targeted tumour therapy-dawn of a new era	2008
Vectorization	[9]	Ryan R.M. and al.	Use of bacteria in anti-cancer therapies	2005
Vectorization	[10]	Mehnert	Solid lipid nanoparticles: Production, characterization and applications	2001
Vectorization	[11]	Lasic D.D.	Liposomes in gene therapy	1996
Vectorization	[12]	Lutten J. and al.	Biodegradable polymers as non-viral carriers for plasmid DNA delivery	2008
Vectorization	[13]	Jiskoot W. and al.	Immunological Risk of Injectable Drug Delivery Systems	2009
Vectorization	[14]	Head M. and al.	Mechanism and computer simulation of immune complex formation, opsonization, and clearance	1996
Vectorization	[15]	Koide H. and al.	Particle size-dependent triggering of accelerated blood clearance phenomenon	2008
Vectorization	[16]	Ishida T. and al.	Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes	2005
Vectorization	[17]	Wang XY and al.	Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes	2007
Vectorization	[18]	Tosi M.F. and al.	Innate immune responses to infection	2005
Vectorization	[19]	Linkov I and al.	Nanotoxicology and nanomedicine: making hard decisions	2008
Tissue Vector	[1]	Ronald S. and al.	Antimicrobial mechanisms of phagocytes and bacterial evasion strategies	2009
Tissue Vector	[2]	Clark B. Inderlied and al.	The Mycobacterium avium Complex	1993
Tissue Vector	[3]	Nisheeth Agarwal and al.	Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase	2009
Tissue Vector	[4]	Hunter R.L. and al.	Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs	2007
Tissue Vector	[5]	Axelrod S and al.	Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide	2008
Tissue Vector	[6]	Nicole N van der Wel and al.	Subcellular localization of mycobacteria in tissues and detection of lipid antigens in organelles using cryo-techniques for light and electron microscopy	2005
Tissue Vector	[7]	Claudia Nobrega and al.	The thymus as a target for mycobacterial infections	2007
Cell Vector	[1]	Harrison Echols and al.	Genetic Map of Bacteriophage Lambda	1978
Cell Vector	[2]	Joseph Sambrook and al.	Molecular Cloning: A Laboratory Manual (Third Edition)	2001
Cell Vector	[3]	Court DL and al.	A New Look at Bacteriophage lambda Genetic Networks	2007
Cell Vector	[4]	Ortega ME and al.	Bacteriophage Lambda gpNu1 and Escherichia coli IHF Proteins Cooperatively Bind and Bend Viral DNA: Implications for the Assembly of a Genome-Packaging Motor	2006
Cell Vector	[5]	Feiss M. and al.	Bactériophage Lambda Terminase and the Mechanism of Viral DNA Packaging	2005
Cell Vector	[6]	Hang JQ and al.	The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB	2001
Cell Vector	[7]	Becker A and al.	Bacteriophage lambda DNA : The begginning of the End	1990
Cell Vector	[8]	Hochschild A and al.	The bactériophage lambda cI protein finds an asymmetric solution	2009
Cell Vector	[9]	Phoebe L.Stewart1 and al.	Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization	1997
Therapeutic Plasmide	[1]	Ortega ME et al.	Bacteriophage lambda gpNu1 and Escherichia coli IHF proteins cooperatively bind and bend viral DNA: implications for the assembly of a genome-packaging motor	2006
Therapeutic Plasmide	[2]	Joseph Sambrook and al.	Molecular Cloning: A Laboratory Manual (Third Edition)	2001
Therapeutic Plasmide	[3]	Court DL and al.	A New Look at Bacteriophage lambda Genetic Networks	2007
Therapeutic Plasmide	[4]	Feiss M. and al.	Viral Genome Packaging Machines: Genetics, Structure and Mechanism	2005
Therapeutic Plasmide	[5]	Hang JQ and al.	The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB	2001
Therapeutic Plasmide	[6]	Becker A and al.	Bacteriophage lambda DNA : The begginning of the End	1990
Therapeutic Plasmide	[7]	Young et al.	Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature	2003
	[]

Back to top

• Recent changes
• What links here
• Related changes
• Special pages
• My preferences

• Printable version
• Permanent link
• Privacy policy
• Disclaimers